Precancerous lesion of the endometrium and endometrial morphology in patients with tamoxifen therapy;Präkanzeröse läsionen des endometriums und veränderungen unter tamoxifen-therapie

Zentralblatt fur Gynakologie

Volumn 124, Issue 1, 2002, Pages 3-9

  Schmidt, Dietmar ^a   Horn, L C ^a  

^a Institute für Pathologie   (Germany)

Author keywords

Carcinoma; Endometrium; Hyperplasia; Pathogenesis; Tamoxifen

Indexed keywords

ESTROGEN; TAMOXIFEN;

ABDOMINAL HYSTERECTOMY; ARTICLE; BREAST CANCER; CANCER RISK; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; HUMAN; MICROSCOPY; MORPHOLOGY;

CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; PRECANCEROUS CONDITIONS; TAMOXIFEN;

EID: 18744429816     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-20315     Document Type: Article

References (38)

1. Assessment of the risk on endometrial cancer in hyperplasia by means of morphological and morphometrical features
2. Kurzgefasste interdisziplinäre AGO-leitlinien für die diagnostik und therapie des endometriumkarzinoms
3. Wirkmechanismen ovarieller steroidhormone und antiöstrogene in der karzinogenese der mamma und des endometriums
4. A multicentric european study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified Working Classification for biopsy and curettage specimens
5. Relative risk of development and active detection of primary multiple endometrial, breast and ovarian cancer
6. Two pathogenic types of endometrial carcinoma
7. Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium
8. Surveillance of the endometrium in tamoxifen treated women
9. Morphologische endometriumveränderungen unter tamoxifen
10. The endometrium in breast cancer patients on tamoxifen
11. Oestrogens and proliferation of endometrial cells
12. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer
13. K-ras activation in permaligant and malignant epithelial lesions of the human uterus
14. Effects of adjuvant Tamoxifen on the endometrium in postmenopausal women with breats cancer: Prospective long-term study using transvaginal ultrasound
15. Charakterisierung und bedeutung verschiedener östrogenrezeptortypen unter besonderer berücksichtigung des endometriumkarzinoms
16. Toward the development of morphologic criteria for well differentiated adenocarcinoma of the endometrium
17. Endometriale hyperplasien: Histologie, klassifikation, prognostische bedeutung und therapie
18. Präkanzeröse läsionen des endometriums: Aspekte der molekularen pathogenese und probleme der nomenklatur
19. Karzinomrisiko endometrialer hyperplasien: Eine kliniko-pathologische analyse von 538 fällen
20. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia and well differentiated carcinoma
21. Steroid receptor expression in endometria from women treated with tamoxifen
22. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients
23. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma
24. Molekulare pathogenese des endometriumkarzinoms
25. PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma
26. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion
27. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients
28. Endometrial intraepithelial neoplasia (EIN): Will it bring order to chaos?
29. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
30. Molecular identification of latent precancers in histologically normal endometrium
31. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40
32. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies
33. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma
34. Zur prävalenz von hyperplastischen und neoplastischen veränderungen des endometriums bei postmenopausalen patientinnen mit mammakarzinom unter tamoxifentherapie
35. Endometrioid neoplasia retrogressive terminology
36. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia
37. Expression of the retinoblastoma-related gene RB2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma